Sonoma Pharmaceuticals (SNOA) Times Interest Earned (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Times Interest Earned of $87.75 for Q1 2026, up 140.13% year-over-year from $36.54 in Q1 2025, and up 255.31% quarter-over-quarter from -$56.5 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Times Interest Earned (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Times Interest Earned history runs 17 years deep, the most recent figure standing at $87.75 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 140.13% year-over-year to $87.75; the TTM figure through Mar 2026 stood at -$410.17 (down 65.84% YoY), while the FY2026 annual figure was -$0.09, up 27.39% from the prior year.
- Times Interest Earned for Q1 2026 stood at $87.75, up from -$56.5 in the prior quarter.
- The five-year high for Times Interest Earned was $87.75 in Q1 2026, with the low at -$255.0 in Q1 2022.
- The 5-year median for Times Interest Earned is -$15.14 (2023), against an average of -$62.67.
- The sharpest annual moves came in 2023 and 2026: Times Interest Earned plunged 1750.85% in 2023, then surged 140.13% in 2026.
- Sonoma Pharmaceuticals' Times Interest Earned stood at -$3.43 in 2022, then slumped by 622.78% to -$24.82 in 2023, then soared by 80.65% to -$4.8 in 2024, then tumbled by 1076.53% to -$56.5 in 2025, then soared by 255.31% to $87.75 in 2026.
- Business Quant data shows SNOA's Times Interest Earned at $87.75 in Q1 2026, -$56.5 in Q4 2025, and -$2.59 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.06 |
| Mar 31, 2026 | 87.75 |
| Dec 31, 2025 | -56.50 |
| Sep 30, 2025 | -2.59 |
| Jun 30, 2025 | -5.45 |
| Mar 31, 2025 | -218.67 |
| Sep 30, 2024 | -4.80 |
| Jun 30, 2024 | -48.88 |
| Mar 31, 2024 | -201.29 |
| Dec 31, 2023 | -24.82 |
| Sep 30, 2023 | -3.09 |
| Jun 30, 2023 | -29.52 |
| Mar 31, 2023 | -229.40 |
| Dec 31, 2022 | -3.43 |
| Sep 30, 2022 | -5.41 |
| Jun 30, 2022 | -1.60 |
| Mar 31, 2022 | -255.00 |
| Dec 31, 2021 | -68.43 |
| Sep 30, 2021 | -1.23 |
| Jun 30, 2021 | -1.13 |